{
  "bio": [
    "Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York-based company.",
    "Schleifer took Regeneron public in 1991; he owns 2% of the company's common stock.",
    "Sales of Regeneron's blockbuster drug Eylea, a treatment for macular degeneration, reached $5.7 billion in the U.S. in 2023.",
    "Regeneron has developed 12 FDA-approved medicines.",
    "Regeneron is working on antibody medicines to prevent and treat people with Covid-19."
  ],
  "about": [
    "Schleifer attended Cornell on scholarship and dreamed of a medical career.",
    "The son of a sweater manufacturer, Schleifer grew up in Queens, New York."
  ]
}